StockNews.com Initiates Coverage on Calithera Biosciences (NASDAQ:CALA)

StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research report released on Tuesday morning. The firm issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

CALA opened at $0.00 on Tuesday. The business has a 50 day simple moving average of $0.02 and a two-hundred day simple moving average of $0.02. Calithera Biosciences has a one year low of $0.00 and a one year high of $0.12.

Calithera Biosciences Company Profile

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.